RN

Ram Nivas Mishra

Active Director Director DIN 08766474
DIN 08766474 First appointment Jun 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Ram Nivas Mishra

Data last updated:

Ram Nivas Mishra is a Director at Teliqon Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Teliqon Pharmaceutical Private Limited reported revenue of ₹5.2 Lakh (FY 2025).

DIN 08766474
Primary Designation Director
Industry Pharma
First Appointment 18 Jun 2020
Oldest Company Age 6 yrs
Largest company Teliqon Pharmaceutical Private Limited · ₹5.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jun 20202020₹5.2 Lakh (FY 2025)Active

Board colleagues of Ram Nivas Mishra

NameDINCompanyDesignation
Rubi Kumari08766475Teliqon Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Teliqon Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ram Nivas Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Nivas Mishra

Ram Nivas Mishra currently holds 1 directorship: Teliqon Pharmaceutical Private Limited (Director, since 18 Jun 2020, revenue ₹5.2 Lakh (FY 2025)).

Ram Nivas Mishra was first appointed on 18 Jun 2020 as Director at Teliqon Pharmaceutical Private Limited.

The current boards of Ram Nivas Mishra's companies include Rubi Kumari (Teliqon Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available